PT Central Proteina Prima Tbk carries a market capitalization of 2.98T, placing it among publicly traded companies globally. Its enterprise value stands at 4.60T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.98T |
| Enterprise Value | 4.60T |
PT Central Proteina Prima Tbk currently has 59.57B shares outstanding.
| Shares Outstanding | 59.57B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
PT Central Proteina Prima Tbk trades at a trailing price-to-earnings ratio of 6.85. The price-to-sales ratio is 0.31, and the price-to-book ratio stands at 1.30.
| PE Ratio | 6.85 |
| PS Ratio | 0.31 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | 14.47 |
| P/OCF Ratio | N/A |
On an enterprise value basis, PT Central Proteina Prima Tbk trades at an EV/EBITDA multiple of 5.14 and an EV/FCF ratio of 14.06. The EV/Sales ratio of 0.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.48 |
| EV / EBITDA | 5.14 |
| EV / EBIT | 5.14 |
| EV / FCF | 14.06 |
PT Central Proteina Prima Tbk maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.82, indicating elevated leverage, while an interest coverage ratio of 5.39 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.07 |
| Quick Ratio | 0.03 |
| Debt / Equity | 43.82 |
| Debt / EBITDA | 1.89 |
| Interest Coverage | 5.39 |
PT Central Proteina Prima Tbk posts a return on equity of 21.00 and a return on invested capital of 11.90.
| Return on Equity (ROE) | 21.00 |
| Return on Assets (ROA) | 6.30 |
| Return on Invested Capital (ROIC) | 11.90 |
| Return on Capital Employed (ROCE) | 14.02 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.99 |
Over the trailing twelve months, PT Central Proteina Prima Tbk has paid 159.39B in income taxes, reflecting an effective tax rate of 26.80.
| Income Tax | 159.39B |
| Effective Tax Rate | 26.80 |
PT Central Proteina Prima Tbk's stock has declined approximately -1.96078% over the past 52 weeks. The 50-day moving average sits at 52.96, while the 200-day moving average is 60.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | -1.96078% |
| 50-Day Moving Average | 52.96 |
| 200-Day Moving Average | 60.49 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, PT Central Proteina Prima Tbk generated 9.54T in revenue and converted that into 434.98B in net income, yielding earnings per share of 7.31. EBITDA reached 895.59B, while operating income came in at 895.59B.
| Revenue | 9.54T |
| Gross Profit | 1.98T |
| Operating Income | 895.59B |
| Pretax Income | 594.69B |
| Net Income | 434.98B |
| EBITDA | 895.59B |
| EBIT | 895.59B |
| Earnings Per Share (EPS) | 7.31 |
PT Central Proteina Prima Tbk holds 72.56B in cash and equivalents against 1.69T in total debt, resulting in a net debt position of 1.54T. Total book value stands at 2.29T, with working capital of 175.06B providing operational flexibility.
| Cash & Cash Equivalents | 72.56B |
| Total Debt | 1.69T |
| Net Debt | 1.54T |
| Equity (Book Value) | 2.29T |
| Book Value Per Share | 38.52 |
| Working Capital | 175.06B |
After subtracting -205.85B in capital expenditures, free cash flow totaled -205.85B - equivalent to -3.46 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -205.85B |
| Free Cash Flow | -205.85B |
| FCF Per Share | -3.46 |
PT Central Proteina Prima Tbk operates with a gross margin of 20.74, reflecting its pricing power and cost economics. The operating margin of 9.39 and net profit margin of 4.56 provide insight into operational efficiency.
| Gross Margin | 20.74 |
| Operating Margin | 9.39 |
| Pretax Margin | 6.24 |
| Profit Margin | 4.56 |
| EBITDA Margin | 9.39 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 17.44 |
| FCF Yield | 6.91 |
PT Central Proteina Prima Tbk posts an Altman Z-Score of 1.90, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.90 |